The role of fractional exhaled nitric oxide in the assessment of athletes reporting exertional dyspnoea

Allen, Hayden, Hull, James H., Backhouse, Susan H., Dickinson, John W., De Carné, Taidgh, Dimitriou, Lygeri ORCID: https://orcid.org/0000-0002-5093-558X and Price, O. (2019) The role of fractional exhaled nitric oxide in the assessment of athletes reporting exertional dyspnoea. Allergy, Volume 74, Issue S106 Special Issue:Abstracts from the European Academy of Allergy and Clinical Immunology Congress, 01–05 June 2019, Lisbon, Portugal. In: European Academy of Allergy and Clinical Immunology Congress, 01-05 Jun 2019, Lisbon, Portugal. . ISSN 0105-4538 (doi:10.1111/all.13959)

[img] PDF (Abstract-Poster Presentation) - Final accepted version (with author's formatting)
Restricted to Repository staff and depositor only until 8 August 2020.

Download (266kB)

Abstract

Background: Exercise-induced bronchoconstriction (EIB) is a common cause of breathing difficulty in athletes. Fractional exhaled nitric oxide (FeNO) is an indirect marker of airway inflammation, recommended for the assessment and management of asthma; however, the role of FeNO in detecting and monitoring EIB has yet to be fully established. The aim of this study was therefore to evaluate the predictive value of FeNO to confirm or refute EIB in athletes presenting with exertional dyspnoea.

Method: Seventy athletes (male: n = 45) (age: 35 ± 11 years) reporting respiratory symptoms (i.e. wheeze, cough and dyspnoea) during exercise attended the laboratory on a single occasion. All athletes performed resting FeNO and spirometry pre-and-post a eucapnic voluntary hyperpnoea challenge (EVH) in accordance with international guidelines. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated for established FeNO thresholds: (intermediate [≥25ppb] and high [>50ppb]) and evaluated against objective evidence of EIB: (EVH diagnostic cut-off [-10% ΔFEV1 at two consecutive time-points] and [-15% ΔFEV1 at one time-point]). The diagnostic accuracy of FeNO was calculated using receiver operating characteristics area under the curve (ROC-AUC).

Results: All had normal resting lung function (>80% FEV1 pred). The prevalence of EIB was 33% (-10% ΔFEV1) and 23% (-15% ΔFEV1) (median (IQR) ΔFEV1 = -7% (10.02)). FeNO values ≥25ppb and >50ppb were observed in 49% and 23% of the cohort, respectively. ROC-AUC for FeNO was 75% (-10% ΔFEV1) and 86% (-15% ΔFEV1). Sensitivity, specificity, PPV and NPV are presented in Table 1.

Conclusion: Our findings indicate that FeNO >50ppb provides good specificity for a positive EVH test; however, should not replace indirect bronchoprovocation for diagnostic purposes. The high proportion of athletes reporting breathing difficulty in the absence of EIB highlights the requirement to consider alternative causes of exertional dyspnoea during clinical work-up.

Item Type: Conference or Workshop Item (Poster)
Research Areas: A. > School of Science and Technology > Natural Sciences
Item ID: 27611
Notes on copyright: This is the accepted abstract published in peer reviewed version of the following article: (2019), Abstracts PDS. Allergy, 74: 130-331. doi:10.1111/all.13959, which has been published in final form at https://doi.org/10.1111/all.13959. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Useful Links:
Depositing User: Lygeri Dimitriou
Date Deposited: 23 Sep 2019 20:55
Last Modified: 10 Oct 2019 08:42
URI: https://eprints.mdx.ac.uk/id/eprint/27611

Actions (login required)

Edit Item Edit Item

Full text downloads (NB count will be zero if no full text documents are attached to the record)

Downloads per month over the past year